2
Clinical Trials associated with Allogeneic stem cell therapy(Avicenna Research Institute)Safety and Efficacy Study of Allogeneic Human Menstrual Blood Stem Cells Secretome to Treat Severe Covid-19 Patients, Clinical Trial Phase I&II
In this randomized controlled trial (RCT), severe cases of COVID-19 infection will be treated with secretome of menstrual blood stem cells. The improvement in the clinical, laboratory and radiological manifestations will be evaluated in treated patients compared with the control group.
Outcome of Pregnancy in Poor Ovarian Responders by Intraovarian Administration of Autologous Menstrual Blood Derived-Mesenchymal Stromal Cells
In this controlled trial, poor ovarian responder women will be treated with transplantation of autologous menstrual blood stem cells. The investigators will attempt to assess the safety and efficacy of this procedure for the treatment of infertility in POR patients compared to control group.
100 Clinical Results associated with Allogeneic stem cell therapy(Avicenna Research Institute)
100 Translational Medicine associated with Allogeneic stem cell therapy(Avicenna Research Institute)
100 Patents (Medical) associated with Allogeneic stem cell therapy(Avicenna Research Institute)
100 Deals associated with Allogeneic stem cell therapy(Avicenna Research Institute)